Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan.
Anticoagulants
Cancer
DIC
Descriptive studies
Leukemia
Mortality trends
Sepsis
Journal
JMA journal
ISSN: 2433-3298
Titre abrégé: JMA J
Pays: Japan
ID NLM: 101769797
Informations de publication
Date de publication:
15 Oct 2020
15 Oct 2020
Historique:
received:
05
03
2020
accepted:
05
06
2020
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
24
11
2020
Statut:
ppublish
Résumé
Existing evidence on the mortality time trends of patients with disseminated intravascular coagulation (DIC) is limited, and whether the mortality trend or quality of care of DIC patients has improved remains unknown. This study aimed to investigate the temporal trend in mortality, patient outcomes, and treatment preferences of several anticoagulants in Japan. This retrospective observational study used the Japanese Diagnosis Procedure Combination inpatient database, which contains data from more than 1200 acute-care hospitals in Japan. We identified all adult patients that were diagnosed with DIC from July 2010 to March 2018 and sorted them into one of five predefined underlying conditions: sepsis, solid cancer, leukemia, trauma, or obstetric. The data collected as general outcomes were the 28-day mortality and major bleeding events. We also evaluated anticoagulant use for DIC treatment. A total of 325,327 DIC patients were included in this study. Regarding the baseline characteristics, an increase in median age, worsened comorbid conditions, and higher illness severity were observed over time. The underlying conditions for DIC were largely unchanged. Over the study period, the 28-day mortality for overall DIC patients decreased from 41.8% (95% CI 41.2%-42.3%) to 36.1% (95% CI 35.6%-36.6%), which is a 14% decrease over the 8-year period ( The overall 28-day mortality for DIC patients clearly decreased from 2010 to 2017. The downward trend in mortality might have resulted from the advances made in the fundamental treatment of underlying diseases and from the changes in anti-DIC strategies.
Identifiants
pubmed: 33225103
doi: 10.31662/jmaj.2020-0013
pmc: PMC7677444
doi:
Types de publication
Journal Article
Langues
eng
Pagination
313-320Informations de copyright
Copyright © Japan Medical Association.
Déclaration de conflit d'intérêts
None
Références
J Thromb Haemost. 2018 Mar;16(3):462-464
pubmed: 29316171
Cochrane Database Syst Rev. 2016 Feb 08;2:CD005370
pubmed: 26858174
Intensive Care Med. 2010 Feb;36(2):222-31
pubmed: 20069275
Thromb Res. 2019 Jun;178:182-188
pubmed: 31054468
Thromb Res. 2010 Jan;125(1):6-11
pubmed: 19782389
J Epidemiol. 2017 Oct;27(10):476-482
pubmed: 28142051
Br J Haematol. 2009 Apr;145(1):24-33
pubmed: 19222477
Cancer Epidemiol. 2018 Apr;53:105-110
pubmed: 29414629
JAMA. 2008 May 21;299(19):2294-303
pubmed: 18492971
Crit Care Med. 2015 Jan;43(1):3-12
pubmed: 25275252
Cancer Epidemiol. 2018 Feb;52:55-62
pubmed: 29223104
J Thromb Haemost. 2016 Mar;14(3):518-30
pubmed: 26670422
Nat Rev Dis Primers. 2016 Jun 02;2:16037
pubmed: 27250996
Crit Care. 2014 Apr 03;18(2):R61
pubmed: 24708802
J Thromb Thrombolysis. 2014 Oct;38(3):364-71
pubmed: 24823684
N Engl J Med. 2005 Sep 29;353(13):1332-41
pubmed: 16192478
Cochrane Database Syst Rev. 2012 Dec 12;12:CD004388
pubmed: 23235609
N Engl J Med. 2001 Mar 8;344(10):699-709
pubmed: 11236773
Chest. 2013 May;143(5):1235-1242
pubmed: 23139140
J Obstet Gynaecol Can. 2012 Apr;34(4):341-347
pubmed: 22472333
Thromb Res. 2012 May;129(5):e177-84
pubmed: 21930293
Ann Intern Med. 2014 Nov 18;161(10):690-8
pubmed: 25402512
J Thromb Haemost. 2013 Feb 4;:
pubmed: 23379279
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
Thromb Haemost. 2001 Nov;86(5):1327-30
pubmed: 11816725
JAMA. 2003 Jul 9;290(2):238-47
pubmed: 12851279
Clin Appl Thromb Hemost. 2016 Jan;22(1):21-7
pubmed: 25736054
Front Med (Lausanne). 2015 Feb 26;2:7
pubmed: 25767801
N Engl J Med. 2012 May 31;366(22):2055-64
pubmed: 22616830
J Thromb Haemost. 2015 Jan;13(1):31-40
pubmed: 25393713
JAMA. 2001 Oct 17;286(15):1869-78
pubmed: 11597289
JAMA. 2019 May 28;321(20):1993-2002
pubmed: 31104069
J Epidemiol. 2016 Oct 5;26(10):530-537
pubmed: 27064132
Crit Care. 2013 Jun 20;17(3):R111
pubmed: 23787004